BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Press Releases

  New phase III Translational Data Show DiviTum(R) TKa Captures Treatment-Specific Biological Response in Metastatic Breast Cancer

  May 28, 2026

   · 

  3 min read
• Press Releases

  Theolytics’ Ongoing US Phase 1 OCTOPOD-IP Trial of THEO-260 in Ovarian Cancer to be Presented as a Trial in Progress at ASCO 2026

  May 28, 2026

   · 

  3 min read
• Press Releases

  Merz Therapeutics Presents New Research at World Parkinson Congress 2026, Revealing the Hidden Burden of “OFF” Episodes in Parkinson’s Disease

  May 28, 2026

   · 

  4 min read
• Press Releases

  Synklino announces first patient dosed in Phase 1 trial of SYN002 for CMV prevention in kidney transplantation

  May 28, 2026

   · 

  5 min read
• Press Releases

  ViCentra Scales Commercial Manufacturing, Triples Capacity and Strengthens Unit Economics

  May 28, 2026

   · 

  4 min read
• Press Releases

  Anaveon Reports Clinical Benefit of ANV600 in the EXPAND-1 Phase 1 Clinical Trial at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio

  May 28, 2026

   · 

  4 min read
• Press Releases

  Ionis partner GSK announces bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for chronic hepatitis B

  May 28, 2026

   · 

  8 min read
• Press Releases

  InnoCare Announces the Acceptance of New Drug Application for Orelabrutinib in Primary Immune Thrombocytopenia in China

  May 28, 2026

   · 

  3 min read
• Press Releases

  BeOne Medicines Receives Positive Reimbursement Recommendations from CDA-AMC and INESSS for TEVIMBRA in First-Line Nasopharyngeal Carcinoma

  May 28, 2026

   · 

  11 min read
• Press Releases

  HanchorBio to List on Taiwan Innovation Board at NT$120 per Share as HCB101 Clinical Data Support Global Partnering Discussions

  May 28, 2026

   · 

  4 min read